Pricing Log in Create free account

Edesa Biotech, Inc. (EDSA) vs 4D pharma PLC Sponsored ADR (LBPS)

Edesa Biotech, Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. Edesa Biotech, Inc. and 4D pharma PLC Sponsored ADR are of similar size ($37.2M and $36.1M). Edesa Biotech, Inc. has the higher net margin (0.00% vs −2,010.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, 4D pharma PLC Sponsored ADR leads on 9 and Edesa Biotech, Inc. on 4.

Valuation

Metric EDSA LBPS Biotechnology median
P/E n/m n/m 8.50
P/S 70.40 211.23 9.71
P/B 58.02 9.49 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m — 0.64
EV/Sales 38.98 — 9.21
Earnings yield (65.76%) (40.76%) (33.15%)
Free cash flow yield (38.51%) (30.32%) (25.50%)

Profitability

Metric EDSA LBPS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (2,010.89%) 0.00%
Free cash flow margin 0.00% (3,283.80%) 0.00%
Return on equity (531.32%) (155.83%) (56.36%)
Return on assets (102.46%) (77.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDSA LBPS Biotechnology median
Revenue growth (TTM) (43.48%) — 6.02%
EPS growth (last fiscal year) 34.20% 35.04% 30.26%
Revenue growth, 5-year CAGR (15.40%) 21.70% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDSA LBPS Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 2.76 5.21 4.72
Net debt to EBITDA 1.39 0.23 0.96

Dividend

Metric EDSA LBPS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EDSA LBPS Biotechnology median
Market cap 36.08m 37.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack